21 participants
Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-25
- Start Date:
- 2022-10-13
- Completion:
- 2025-01-27
Conditions
- Gynecologic Cancer
- Gynecologic Neoplasms
- Peritoneal Carcinomatosis
- Peritoneal Neoplasms
- Ovarian Cancer
- Ovarian Neoplasms
- Colorectal Cancer
- Colorectal Neoplasms
- Appendiceal Cancer
- Appendiceal Neoplasms
- Cholangiocarcinoma
- Breast Cancer
Interventions
- DRUG
- DIAGNOSTIC_TEST
- PROCEDURE